Clearfield (AP7) Q2 2026 Earnings Report

The call presented a mixed picture: management delivered Q2 sales toward the high end of guidance, showed meaningful sequential backlog growth (+39%) and maintained a strong balance sheet ($147M cash, no debt) while continuing share repurchases. They also highlighted product momentum (NOVA) and a clear strategy to expand into adjacent edge and data center markets. Offsetting these positives are a 15% year-over-year revenue decline, a Q2 net loss (EPS down to -$0.04 from +$0.18 prior year), margin compression (gross margin down ~1.9 percentage points YoY), and significant uncertainty from BEAD funding delays that push meaningful program-related revenue into Fiscal 2027. Overall, the company appears well-capitalized and strategically positioned for longer-term growth, but near-term revenue and profitability are under pressure due to external program timing and supply/financing constraints.

Management guided Q3 FY2026 net sales of $42–$46 million and net income per diluted share of $0.17–$0.21 (based on shares outstanding at the end of Q2, excluding potential future repurchases), with operating expenses expected to remain roughly consistent with Q2; for full-year FY2026 they reiterated net sales of $160–$170 million (about 10% midpoint growth) and net income per share of $0.48–$0.62, with operating expenses as a percent of revenue in line with FY2025. For context, Q2 results included net sales of $34.4 million (near the high end of their $32–$35 million guidance), a gross margin of 32.5% (down from 34.4% year‑over‑year), operating expenses of $13.2 million, a net loss of $0.5 million (‑$0.04 per diluted share), a 39% sequential backlog increase and a 1.3 book‑to‑bill, about $147 million in cash and investments with no debt, and 237,000 shares repurchased for $7.3 million; management expects meaningful BEAD-related revenue in FY2027 while seeing healthy privately financed build activity in FY2026.